NeoGenomics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
NEO Key Statistics
Stock Snapshot
The current NeoGenomics(NEO) stock price is $10.34, with a market capitalization of 1.34B. The stock trades at a price-to-earnings (P/E) ratio of -11.65.
On 2025-11-15, NeoGenomics(NEO) stock moved within a range of $9.70 to $10.44. With shares now at $10.34, the stock is trading +6.6% above its intraday low and -0.9% below the session's peak.
Trading volume for NeoGenomics(NEO) stock has reached 2.01M, versus its average volume of 2.48M.
Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $19.12 and a low of $4.72.
Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $19.12 and a low of $4.72.
NEO News
NeoGenomics recently reported its third quarter 2025 results with sales of US$187.8 million, year-over-year revenue growth, and a wider quarterly net loss, whil...
